ReviewJournal for immunotherapy of cancer2025

Reprogramming tumor-associated macrophages using STING or TLR agonists: a promising strategy to enhance immunotherapy in hormone-dependent cancers.

Victor Sacristan Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.